Página 2 - Melhores Metástases hepáticas médicos em Turquia - TOP-31 médicos

Professor de Oncologia Médica com foco em oncologia gastrointestinal – o Dr. Saglam traz ampla experiência no tratamento de metástases hepáticas.

• Mais de 20 anos de experiência em oncologia médica
• Especialização (Fellowship) em oncologia gastrointestinal
• Membro de sociedades de prestígio, incluindo ESMO e ASCO
• Atua no Hospital Gayrettepe Florence Nightingale

O Professor Associado Dr. Emrah Eraslan é especialista em metástases hepáticas, trazendo uma vasta experiência em oncologia para o Hospital Koru Ankara.

• Especialista em medicina interna com mais de 12 anos de experiência
• Formação em oncologia médica no Hospital de Formação e Investigação em Oncologia Dr. Abdurrahman Yurtaslan de Ancara
• Investigador publicado que contribui para os avanços no tratamento do cancro
• Os seus interesses especiais incluem cancros colorretal e de estômago – fontes comuns de metástases hepáticas

Mais de 2500 sessões de radioterapia realizadas com MR-Linac – o Prof. Dr. Turkkan é especialista em técnicas avançadas de radiação no Hospital Hisar Intercontinental.

• Ser especialista em radioterapia estereotáxica e guiada por RM
• Ser membro da Sociedade Europeia de Radioterapia e Oncologia (ESTRO)
• Publicar 27 artigos em revistas nacionais e internacionais
• Obter o título de professor associado em fevereiro de 2023

O Dr. Topcu formou-se no MD Anderson Cancer Center e especializa-se no tratamento do cancro do fígado no Hospital Universitário Biruni.

• Especialista certificado em oncologia médica com 9 anos de experiência
• Membro da ESMO e da ASCO – segue protocolos de tratamento internacionais
• Formado nos melhores centros de oncologia nos EUA e no Canadá
• Especializado em cancros gastrointestinais e do fígado

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.